Przejdź do zawartości
Merck

An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells.

The EMBO journal (2020-12-08)
Mart M Lamers, Jelte van der Vaart, Kèvin Knoops, Samra Riesebosch, Tim I Breugem, Anna Z Mykytyn, Joep Beumer, Debby Schipper, Karel Bezstarosti, Charlotte D Koopman, Nathalie Groen, Raimond B G Ravelli, Hans Q Duimel, Jeroen A A Demmers, Georges M G M Verjans, Marion P G Koopmans, Mauro J Muraro, Peter J Peters, Hans Clevers, Bart L Haagmans
ABSTRAKT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which may result in acute respiratory distress syndrome (ARDS), multiorgan failure, and death. The alveolar epithelium is a major target of the virus, but representative models to study virus host interactions in more detail are currently lacking. Here, we describe a human 2D air-liquid interface culture system which was characterized by confocal and electron microscopy and single-cell mRNA expression analysis. In this model, alveolar cells, but also basal cells and rare neuroendocrine cells, are grown from 3D self-renewing fetal lung bud tip organoids. These cultures were readily infected by SARS-CoV-2 with mainly surfactant protein C-positive alveolar type II-like cells being targeted. Consequently, significant viral titers were detected and mRNA expression analysis revealed induction of type I/III interferon response program. Treatment of these cultures with a low dose of interferon lambda 1 reduced viral replication. Hence, these cultures represent an experimental model for SARS-CoV-2 infection and can be applied for drug screens.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
1,4-Dithioerythritol, ≥99.0%
Roche
Red Blood Cell Lysis Buffer, solution, Roche, pkg of 100 mL, sufficient for 50-500 reactions
Sigma-Aldrich
Anti-LPCAT1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1